sm

Steve Mott joins DrugLogic

pharmafile | October 5, 2011 | Appointment | Research and Development |  appointment, outcomes research, personalised medicine, pharmacovigilance, research and development 

Former Datapharm Communications chief executive Steve Mott has been apppointed UK managing director by DrugLogic.

The US firm develops analytical tools that help companies manage real world clinical data and Steve will oversee its expansion into Europe.

Related Content

AI in pharma: From lab development to patient impact

In the decade to 2025, AI use in vaccine development has increased markedly but is …

PlasmidFactory founder Dr. Martin Schleef honoured with the NRW Innovation Award 2025

The founder and long-standing CEO of PlasmidFactory, Dr. Martin Schleef, was honoured in Düsseldorf with …

AAX Biotech announces collaboration for cardiovascular antibody therapy

Swedish biotech firm AAX Biotech has entered a new collaboration focused on the development of …

The Gateway to Local Adoption Series

Latest content